Structure of single-disulfide variants of bovine pancreatic trypsin inhibitor (BPTI) as probed by their binding to bovine β-trypsin

Journal of Molecular Biology

Volumn 275, Issue 3, 1998, Pages 503-513

  Krokoszynska, Izabela ^a   Dadlez, Michal ^b   Otlewski, Jacek ^a  

^a UNIVERSITY OF WROC AW   (Poland)

^b INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

Bovine pancreatic trypsin inhibitor; Disulfide bond; Protein protein recognition; Proteinase binding loop; Trypsin

Indexed keywords

ALANINE; APROTININ; CYSTEINE; TRYPSIN;

AMINO ACID SUBSTITUTION; ARTICLE; CATTLE; DISULFIDE BOND; ESCHERICHIA COLI; EXPRESSION VECTOR; HYDROPHOBICITY; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN VARIANT;

BOS TAURUS; BOVINAE; ESCHERICHIA COLI;

EID: 0032559368     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1997.1460     Document Type: Article

References (76)

1. Ako H., Foster R. J., Ryan C. A. A preparation of anhydro-trypsin and its reactivity with naturally occurring proteinase inhibitors. Biochem. Biophys. Res. Commun. 47:1972;1402-1407.
2. Amir D., Haas E. Reduced bovine pancreatic trypsin inhibitor has a compact structure. Biochemistry. 27:1988;8889-8893.
3. Amir D., Krausz S., Haas E. Detection of local structures in reduced unfolded bovine pancreatic trypsin inhibitor. Proteins: Struct. Funct. Genet. 13:1992;162-173.
4. Antonini E., Ascenzi P., Bolognesi M., Gatti G., Guarneri M., Menegatti E. Interaction between serine (pro)enzymes , and Kazal and Kunitz inhibitors. J. Mol. Biol. 165:1983;543-558.
5. Arnoux B., Merigeau K., Saludjian P., Norris F., Norris K., Bjorn S., Olsen O., Petersen L., Ducruix A. The 1.6 Å structure of Kunitz-type domain from the α3 chain of human type VI collagen. J. Mol. Biol. 246:1995;609-617.
6. Barbar E., Barany G., Woodward C. Dynamic structure of a highly ordered β-sheet molten globule: multiple conformations with a stable core. Biochemistry. 34:1995;11423-11434.
7. Barbar E., LiCata V. J., Barany G., Woodward C. Local fluctuations and global unfolding of partially folded BPTI detected by NMR. Biophys. Chem. 64:1997;45-57.
8. Berndt K. D., Guntert P., Orbons L. P., Wuthrich K. Determination of a high quality nuclear magnetic resonance solution structure of the bovine pancreatic trypsin inhibitor and comparison with three crystal structures. J. Mol. Biol. 227:1992;757-775.
9. Betz S. F. Disulfide bonds and the stability of globular proteins. Protein Sci. 2:1993;1551-1558.
10. Bode W., Huber R. Natural protein proteinase inhibitors and their interaction with proteinases. Eur. J. Biochem. 204:1992;433-451.
11. Chase T., Shaw E. Titration of trypsin, plasmin and thrombin with p -nitrophenyl p′-guanidinobenzoate. Methods Enzymol. 19:1970;20-27.
12. Creighton T. E. Renaturation of the reduced bovine pancreatic trypsin inhibitor. J. Mol. Biol. 87:1974;563-577.
13. Creighton T. E. Electrophoretic analysis of the unfolding of proteins by urea. J. Mol. Biol. 129:1979;235-264.
14. Creighton T. E. On the relevance of non-random polypeptide conformations for protein folding. Biophys. Chem. 31:1988;155-162.
15. Creighton T. E. Disulphide bonds between cysteine residues. Creighton T. E. Protein Structure. A Practical Approach. 1989;155-166 IRL Press, Oxford.
16. Creighton T. E., Goldenberg D. P. Kinetic role of the meta-stable native like two disulfide species in the folding transition of bovine pancreatic trypsin inhibitor. J. Mol. Biol. 179:1984;497-526.
17. Creighton T. E., Charles I. G. Biosynthesis, processing, and evolution of bovine pancreatic trypsin inhibitor. Cold Spring Harbor Symp. Quant. Biol. 52:1987;511-519.
18. Dadlez M. Hydrophobic interactions accelerate early stages of the folding of BPTI. Biochemistry. 36:1997;2788-2797.
19. Dadlez M., Kim P. S. A third native one-disulphide intermediate in the folding of bovine pancreatic trypsin inhibitor. Nature Struct. Biol. 2:1995;674-679.
20. Dadlez M., Kim P. S. Rapid formation of the native 14-38 disulfide bond in the early stages of BPTI folding. Biochemistry. 35:1996;16153-16164.
21. Darby N. J., van Mierlo C. P. M., Creighton T. E. The 5-55 single-disulfide intermediate in folding of bovine pancreatic trypsin inhibitor. FEBS Letters. 279:1991;61-64.
22. Deisenhofer J., Steigemann W. Crystallographic refinement of the structure of bovine pancreatic trypsin inhibitor at 1.5 Å resolution. Acta Crystallog. sect. B. 31:1975;238-250.
23. Doering, D. 1992, Functional and structural studies of a small F-actin binding domain PhD thesis, Massachusetts Institute of Technology, Cambridge, MA, USA.
24. Eigenbrot C., Randal M., Kossiakoff A. A. Structural effects induced by removal of a disulfide-bridge: the X-ray structure of the C30A/C51A mutant of basic pancreatic trypsin inhibitor at 1.6 Å Protein Eng. 3:1990;591-598.
25. Eigenbrot C., Randal M., Kossiakoff A. A. Structural effects induced by mutagenesis affected by crystal packing factors: the structure of a 30-51 disulfide mutant of basic pancreatic trypsin inhibitor. Proteins: Struct. Funct. Genet. 14:1992;75-87.
26. Empie M., Laskowski M. Jr. Thermodynamics and kinetics of single residue replacements in avian ovomucoid third domains: effect of inhibitor interactions with serine proteinases. Biochemistry. 21:1982;2274-2284.
27. Ferrer M., Barany G., Woodward C. Partially folded, molten globule and molten coil states of bovine pancreatic trypsin inhibitor. Nature Struct. Biol. 2:1995;211-217.
28. Fiedler F. Effects of secondary interactions on the kinetics of peptide and peptide ester hydrolysis by tissue kallikrein and trypsin. Eur. J. Biochem. 163:1987;303-312.
29. Finkenstadt W. R., Hamid M. A., Mattis J. A., Schrode J., Sealock R. W., Laskowski M. Kinetics and thermodynamics of the interaction of proteinases with protein inhibitors. Fritz H., Tschesche H., Green L. J. Bayer Symp. V. 1974;389-411 Springer Verlag, Berlin.
30. Flory P. Theory of elastic mechanism in fibrous proteins. J. Am. Chem. Soc. 78:1956;5222-5235.
31. Goldenberg D. P. Native and non-native intermediates in the BPTI folding pathway. Trends Biochem. Sci. 17:1992;257-261.
32. Goldenberg D. P., Zhang J. Small effects of amino acid replacements on the reduced and unfolded state of pancreatic trypsin inhibitor. Struct. Funct. Genet. 6:1993;259-266.
33. Gottfried D. S., Haas E. Nonlocal interactions stabilize compact folding intermediates in reduced unfolded bovine pancreatic trypsin inhibitor. Biochemistry. 31:1992;12353-12362.
34. Gussakovsky E. E., Haas E. The compact state of reduced bovine pancreatic trypsin inhibitor is not the compact molten globule. FEBS Letters. 308:1992;146-148.
35. Housset D., Kim K.-S., Fuchs J., Woodward C., Wlodawer A. Crystal structure of a Y35G mutant of bovine pancreatic trypsin inhibitor. J. Mol. Biol. 220:1991;757-770.
36. Hynes T. R., Randal M., Kennedy L. A., Eigenbrot C., Kossiakoff A. A. X-ray crystal structure of the inhibitor domain of Alzheimer's amyloid β-protein precursor. Biochemistry. 29:1990;10018-10022.
37. Kemmink J., Creighton T. E. Local conformations of peptides representing the entire sequence of bovine pancreatic trypsin inhibitor and their roles in folding. J. Mol. Biol. 234:1993;861-878.
38. 1H-nuclear magnetic resonance spectroscopy in a peptide related to the N terminus of bovine pancreatic trypsin inhibitor. J. Mol. Biol. 230:1993;312-322.
39. Kitchell J. P., Dyckes D. F. A synthetic 13-residue peptide designed to resemble the primary binding site of the basic pancreatic trypsin inhibitor. Biochim. Biophys. Acta. 701:1982;149-152.
40. Kosen P. A., Creighton T. E., Blout E. R. Ultraviolet difference spectroscopy of intermediates trapped in unfolding and refolding of bovine pancreatic trypsin inhibitor. Biochemistry. 19:1980;4936-4944.
41. Kosen P. A., Creighton T. E., Blout E. R. Circular dichroism spectroscopy of bovine pancreatic trypsin inhibitor and five altered conformational states. Relationship of conformation and the refolding pathway of the trypsin inhibitor. Biochemistry. 20:1981;5744-5754.
42. Kraulis P. MolScript, a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallog. 24:1991;946-950.
43. Kunkel T. A., Roberts J. D., Zakour R. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:1987;367-382.
44. Leatherbarrow R. J., Salacinski H. J. Design of small peptide-based proteinase inhibitor by modeling the active site region of barley chymotrypsin inhibitor. Biochemistry. 30:1991;10717-10721.
45. Lumb K. J., Kim P. S. Formation of a hydrophobic cluster in denatured bovine pancreatic trypsin inhibitor. J. Mol. Biol. 236:1994;412-420.
46. 1H NMR determination of the three-dimensional structures of mirror-image forms of a Leu-5 variant of the trypsin inhibitor from Ecballium eleaterium (EET II). Protein Sci. 3:1994;291-302.
47. Oas T. G., Kim P. S. A peptide model of a protein folding intermediate. Nature. 336:1988;42-48.
48. Otlewski J., Zbyryt T. Single peptide bond hydrolysis/resysnthesis in squash inhibitor of serine proteinases. 1. Kinetics and thermodynamics of the interaction between squash inhibitors and bovine β-trypsin. Biochemistry. 33:1994;200-207.
49. Otlewski J., Zbyryt T., Krokoszyńska. I., Wilusz T. Inhibition of serine proteinases by squash inhibitors. Biol. Chem. Hoppe-Seyler. 371:1990;589-594.
50. Pan H., Barbar E., Barany G., Woodward C. Extensive non-random structure in reduced and unfolded bovine pancreatic trypsin inhibitor. Biochemistry. 34:1995;13974-13981.
51. Price-Carter M., Gray W. R., Goldenberg D. P. Folding of ω-conotoxins. 1. Efficient disulfide coupled folding of mature sequences in vitro. Biochemistry. 35:1996;15537-15546.
52. Rheinnecker M., Eder J., Pandey P. S., Fersht A. R. Variants of subtilisin BPN′ with altered specificity profiles. Biochemistry. 33:1994;221-225.
53. Roder, H. 1981, Interne Mobilität in Proteinen unter nativen und denaturierenden Bedinungen PhD thesis no. 6932, ETH, Zurich.
54. Schechter P., Berger A. On the size of the active site in proteases. L. Papain. Biochem. Biophys. Res. Commun. 27:1067;157-162.
55. Staley J. P. PhD thesis. 1993;Massachusetts Institute of Technology, Cambridge.
56. Staley J. P., Kim P. S. Role of a subdomain in the folding of bovine pancreatic trypsin inhibitor. Nature. 344:1990;685-688.
57. Staley J. P., Kim P. S. Complete folding of bovine pancreatic trypsin inhibitor with only a single disulphide bond. Proc. Natl Acad. Sci. USA. 89:1992;1519-1523.
58. Staley J. P., Kim P. S. Formation of a native-like subdomain in a partially-folded intermediate of bovine pancreatic trypsin inhibitor. Protein Sci. 10:1994;1822-1832.
59. States D. J., Creighton T. E., Dobson C. M., Karplus M. Conformations of intermediates in the folding of the pancreatic trypsin inhibitor. J. Mol. Biol. 195:1987;731-739.
60. Studier F. W., Rosenberg A. H., Dunn J. J., Dubendorff J. W. Use of T7 polymerase to direct expression of cloned genes. Methods Enzymol. 185:1990;60-89.
61. 1H nuclear magnetic resonance study. J. Mol. Biol. 222:1991a;353-371.
62. 1H NMR study of the (5-55) single disulphide intermediate of bovine pancreatic trypsin inhibitor. J. Mol. Biol. 222:1991b;373-390.
63. van Mierlo C. P. M., Darby N. J., Neuhuas D., Creighton T. E. The partially folded conformation of the Cys30-Cys51 intermediate in the disulphide folding pathway of bovine pancreatic trypsin inhibitor. Proc. Natl Acad. Sci. USA. 89:1992;6775-6779.
64. 15N relaxation measurements. J. Mol. Biol. 229:1993;1125-1146.
65. 1H NMR analysis of the partly folded non-native two-disulphide intermediates (30-51, 5-14) and (30-51, 5-38) in the folding pathway of bovine pancreatic trypsin inhibitor. J. Mol. Biol. 235:1994;1044-1061.
66. Wagner G., Braun W., Havel T. F., Schaumann T., Go N., Wuthrich K. Protein structures in solution by nuclear magnetic resonance and distance geometry. The polypeptide of the basic pancreatic trypsin inhibitor determined using two different algorithms, DISGEO and DISMAN. J. Mol. Biol. 196:1982;611-639.
67. Weissman J. S., Kim P. S. Re-examination of the folding of BPTI: predominance of native intermediates. Science. 253:1991;1386-1393.
68. Weissman J. S., Kim P. S. Kinetic role of non-native species in the folding of bovine pancreatic trypsin inhibitor. Proc. Natl Acad. Sci. USA. 89:1992a;9900-9904.
69. Weissman J. S., Kim P. S. The pro region of BPTI facilitates folding. Cell. 71:1992b;841-851.
70. Weissman J. S., Kim P. S. Efficient catalysis of disulfide rearrangements by protein disulfide isomerase. Nature. 365:1993;185-188.
71. Weissman J. S., Kim P. S. A kinetic explanation for the rearrangement pathway of BPTI folding. Nature Struct. Biol. 2:1995;1123-1130.
72. Wlodawer A., Walter J., Huber R., Sjolin L. Structure of bovine pancreatic trypsin inhibitor. Results of joint neutron and X-ray refinement of crystal form II. J. Mol. Biol. 180:1984;301-329.
73. Wlodawer A., Nachman J., Gilliand G. L., Gallagher W., Woodward C. Structure of form III crystals of bovine pancreatic trypsin inhibitor. J. Mol. Biol. 198:1987;469-480.
74. Wolfson A. J., Kanaoka M., Lau F. T. K., Ringe D. Insertion of an elastase binding loop into interleukin-1β Protein Eng. 4:1991;313-317.
75. Yu M.-H., Weissman J. S., Kim P. S. Contribution of individual side-chains to the stability of BPTI examined by alanine-scanning mutagenesis. J. Mol. Biol. 249:1995;388-397.
76. Zweckstetter M., Czisch M., Mayer U., Chu M.-L., Zinth W., Timpl R., Holak T. A. Structure and multiple conformations of the Kunitz-type domain from human type VI collagen α3(VI) chain in solution. Structure. 4:1996;195-209.